AlphaFold predicted structure
HDAC8 · Q9BY41

Mean pLDDT
95.3/ 100
Very high
377 residues
Confidence breakdown
- Very high(≥ 90)92%
- Confident(70–90)4%
- Low(50–70)1%
- Very low(< 50)3%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
histone deacetylase 8
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Clefting
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)DDG2P
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)Fetal anomalies
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)Intellectual disability
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)IUGR and IGF abnormalities
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)Limb disorders
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)Radial dysplasia
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)Severe microcephaly
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)+2 more panels — install the extension to see the full list inline on any page.
Cornelia de Lange syndrome
Wilson-Turner syndrome
neoplasm
plasma cell myeloma
hereditary disease
Duchenne muscular dystrophy
peripheral T-cell lymphoma, not otherwise specified
Intellectual disability
mature T-cell and NK-cell non-Hodgkin lymphoma
primary cutaneous T-cell non-Hodgkin lymphoma
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Histone deacetylase 8
Histone deacetylase that catalyzes the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4) (PubMed:10748112, PubMed:10922473, PubMed:10926844, PubMed:14701748, PubMed:28497810). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events (PubMed:10748112, PubMed:10922473, PubMed:10926844, PubMed:14701748). Histone deacetylases act via the formation of large multiprotein complexes (PubMed:10748112, PubMed:10922473, PubMed:10926844, PubMed:14701748). Also involved in the deacetylation of cohesin complex protein SMC3 regulating release of cohesin complexes from chromatin (PubMed:22885700). May play a role in smooth muscle cell contractility (PubMed:15772115). In addition to protein deacetylase activity, also has protein-lysine deacylase activity: acts as a protein decrotonylase by mediating decrotonylation ((2E)-butenoyl) of histones (PubMed:28497810)
HDAC8 · Q9BY41

Mean pLDDT
95.3/ 100
Very high
377 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0